Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript March 10, 2025
Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $0.56.
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions...
